Trial
NCT01735396
Abiraterone Acetate Trial in African American Prostate Cancer Patients
Phase IITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Icahn School of Medicine at Mount Sinai
Collaborators
—
Condition
Prostate Cancer
Intervention
Abiraterone Acetate
Why stopped
poor accrual
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2017-05-12